Literature DB >> 9393836

A systemic downregulation of gamma interferon production is associated with acute shigellosis.

R Raqib1, A Gustafsson, J Andersson, M Bakhiet.   

Abstract

Production of cytokines by peripheral blood mononuclear cells from Shigella-infected patients was assessed. The frequencies of tumor necrosis factor alpha (TNF-alpha), TNF-beta, and transforming growth factor beta mRNA-expressing cells were persistently upregulated during the course of shigellosis in comparison to those of healthy controls. In contrast, the frequency of gamma interferon (IFN-gamma) mRNA-expressing cells was significantly reduced during the acute stage compared to that during the convalescent stage and to that of healthy Bangladeshi controls (P < 0.01). Constitutive IFN-gamma production in Bangladeshi controls was significantly upregulated compared to that in Swedish controls.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9393836      PMCID: PMC175769          DOI: 10.1128/iai.65.12.5338-5341.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  Sensitive mRNA detection using unfixed tissue: combined radioactive and non-radioactive in situ hybridization histochemistry.

Authors:  A Dagerlind; K Friberg; A J Bean; T Hökfelt
Journal:  Histochemistry       Date:  1992-08

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Expression of human immune interferon cDNA in E. coli and monkey cells.

Authors:  P W Gray; D W Leung; D Pennica; E Yelverton; R Najarian; C C Simonsen; R Derynck; P J Sherwood; D M Wallace; S L Berger; A D Levinson; D V Goeddel
Journal:  Nature       Date:  1982-02-11       Impact factor: 49.962

4.  Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin.

Authors:  D Pennica; G E Nedwin; J S Hayflick; P H Seeburg; R Derynck; M A Palladino; W J Kohr; B B Aggarwal; D V Goeddel
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

5.  Isolation and characterization of a human interleukin cDNA clone, homologous to mouse B-cell stimulatory factor 1, that expresses B-cell- and T-cell-stimulating activities.

Authors:  T Yokota; T Otsuka; T Mosmann; J Banchereau; T DeFrance; D Blanchard; J E De Vries; F Lee; K Arai
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

6.  Interleukin 6: identification as a hematopoietic colony-stimulating factor.

Authors:  G G Wong; J Witek-Giannotti; R M Hewick; S C Clark; M Ogawa
Journal:  Behring Inst Mitt       Date:  1988-08

7.  Persistence of local cytokine production in shigellosis in acute and convalescent stages.

Authors:  R Raqib; A A Lindberg; B Wretlind; P K Bardhan; U Andersson; J Andersson
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

8.  Number of interleukin-4- and interferon-gamma-secreting human T cells reactive with tetanus toxoid and the mycobacterial antigen PPD or phytohemagglutinin: distinct response profiles depending on the type of antigen used for activation.

Authors:  G E elGhazali; S Paulie; G Andersson; Y Hansson; G Holmquist; J B Sun; T Olsson; H P Ekre; M Troye-Blomberg
Journal:  Eur J Immunol       Date:  1993-11       Impact factor: 5.532

9.  Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells.

Authors:  R Derynck; J A Jarrett; E Y Chen; D H Eaton; J R Bell; R K Assoian; A B Roberts; M B Sporn; D V Goeddel
Journal:  Nature       Date:  1985 Aug 22-28       Impact factor: 49.962

10.  Purification of Shiga toxin by alpha-D-galactose-(1----4)-beta-D-galactose-(1----4)-beta-D-glucose-(1- ---) receptor ligand-based chromatography.

Authors:  M Ryd; H Alfredsson; L Blomberg; A Andersson; A A Lindberg
Journal:  FEBS Lett       Date:  1989-12-04       Impact factor: 4.124

View more
  9 in total

Review 1.  Use of Pathogen-Specific Antibody Biomarkers to Estimate Waterborne Infections in Population-Based Settings.

Authors:  Natalie G Exum; Nora Pisanic; Douglas A Granger; Kellogg J Schwab; Barbara Detrick; Margaret Kosek; Andrey I Egorov; Shannon M Griffin; Christopher D Heaney
Journal:  Curr Environ Health Rep       Date:  2016-09

2.  An update on vaccines against Shigella.

Authors:  Shai Ashkenazi; Dani Cohen
Journal:  Ther Adv Vaccines       Date:  2013-09

3.  Parameters underlying successful protection with live attenuated mutants in experimental shigellosis.

Authors:  M L Bernardini; J Arondel; I Martini; A Aidara; P J Sansonetti
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

4.  Antigen-specific CD8(+) T cells fail to respond to Shigella flexneri.

Authors:  Stephanie P Jehl; Amy M Doling; Kara S Giddings; Armelle Phalipon; Philippe J Sansonetti; Marcia B Goldberg; Michael N Starnbach
Journal:  Infect Immun       Date:  2011-02-28       Impact factor: 3.441

5.  Shigella outer membrane protein PSSP-1 is broadly protective against Shigella infection.

Authors:  Jae-Ouk Kim; Semi Rho; Su Hee Kim; Heejoo Kim; Hyo Jin Song; Eun Jin Kim; Ryang Yeo Kim; Eun Hye Kim; Anuradha Sinha; Ayan Dey; Jae Seung Yang; Man Ki Song; Ranjan Kumar Nandy; Cecil Czerkinsky; Dong Wook Kim
Journal:  Clin Vaccine Immunol       Date:  2015-02-04

6.  Selective deletion of CD8(+) cells upregulated by caspases-1 via IL-18 in mice immunized with major outer membrane protein of Shigella dysenteriae 1 following infection.

Authors:  Ashim Kumar Bagchi; Ajoy Kumar Sinha; Rushita Adhikari; Pradip Maiti; Joydeep Mukherjee; Arpita Panda; Dhira Rani Saha
Journal:  J Clin Immunol       Date:  2010-01-19       Impact factor: 8.317

7.  Intradermal delivery of Shigella IpaB and IpaD type III secretion proteins: kinetics of cell recruitment and antigen uptake, mucosal and systemic immunity, and protection across serotypes.

Authors:  Shannon J Heine; Jovita Diaz-McNair; Abhay U Andar; Cinthia B Drachenberg; Lillian van de Verg; Richard Walker; Wendy L Picking; Marcela F Pasetti
Journal:  J Immunol       Date:  2014-01-22       Impact factor: 5.422

8.  Evaluation of immunogenicity and protective efficacy of orally delivered Shigella type III secretion system proteins IpaB and IpaD.

Authors:  Shannon J Heine; Jovita Diaz-McNair; Francisco J Martinez-Becerra; Shyamal P Choudhari; John D Clements; Wendy L Picking; Marcela F Pasetti
Journal:  Vaccine       Date:  2013-05-02       Impact factor: 3.641

Review 9.  Bacteria That Cause Enteric Diseases Stimulate Distinct Humoral Immune Responses.

Authors:  Souwelimatou Amadou Amani; Mark L Lang
Journal:  Front Immunol       Date:  2020-09-16       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.